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Background: Syphilis is a sexually transmitted infection (STI) caused by the Treponema pallidum
subspecies pallidum spirochete bacterium. The association of human leukocyte antigen (HLA) with
syphilis has been reported in several populations, but not in the Chinese population. Furthermore,
serology methods have mostly been used in previous studies investigating the association between STIs
and HLA alleles. The objective of this study was to analyze the association of the HLA-DRB1 alleles and
susceptibility to syphilis in the Chinese population.
Methods: A polymerase chain reaction with sequence-speciﬁc primers (PCR-SSP) method was used to
genotype HLA-DRB1 alleles in 196 syphilis patients and 500 healthy controls.
Results: The HLA-DRB1*14 allele was more prevalent in syphilis patients than in the healthy controls
(p = 0.013; corrected p < 0.05).
Conclusions: The allele HLA-DRB1*14 was found to be associated with susceptibility to syphilis in the
Chinese population.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Syphilis is a serious chronic infectious disease. Previous studies
have shown that Treponema pallidum has a moderate to high
probability of transmission during contact between susceptible
and infectious sexual partners, however, differences to early
syphilis response in sexual contacts have been found.1 The
immunological response of the host has long been suggested to
play a critical role in the occurrence and development of syphilis.2,3
Related research is limited because T. pallidum cannot be cultured
in vitro.4 This, coupled with the lack of a suitable animal model for
immunological studies, has greatly hindered research into the
immunobiology of syphilis.
Human leukocyte antigen (HLA) is a very important genetic
marker for humans, with race and regional differences, which
participates in and adjusts immune function.5 The HLA system has
been suggested to play an important role in the mechanism of
sexually transmitted infections (STI).6–9 Several studies have also
reported the association between certain HLA alleles and syphilis,
such as HLA-AW*19, B*17, B*18, A*02, B*07 and AW*32, with
susceptibility or resistance to syphilis or subtypes of syphilis.10–13* Corresponding authors.
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and dendritic cells (DC) by electronmicroscopy, and found that the
expression of HLA-DR on DC slightly increased in the mixed
lymphocyte reaction.14 Salazar et al.15 and McBroom et al.16 have
found a high level expression of HLA-DR among dermal lesions in
secondary syphilis. These studies have not only shown the role of
theHLA locus in susceptibility to syphilis, but have also highlighted
different HLA alleles associated with syphilis in diverse popula-
tions.11
HLA-DRB1 plays a central role in the immune system by
presenting peptides derived from extracellular proteins; it has the
highest polymorphism in the HLA antigen system.17,18 To
investigate the role of the HLA-DRB1 locus in susceptibility to
syphilis in the Chinese population, we analyzed DRB1 alleles in a
large Chinese Han sample of 196 syphilis patients and 500 healthy
controls.
Materials and methods
Patients and controls
The study included 196 unrelated individuals with a diagnosis
of syphilis (95 men and 101 women) and 500 healthy controls
(Table 1).
Patients were recruited from the Clinical Department of the
Shandong Provincial Institute of Dermatovenereology. Theses. Published by Elsevier Ltd. All rights reserved.
Table 1
Sample summary for the 196 cases and 500 controls included in the study
Population Sample size Male/female Mean age,
years
Treated/untreated
Cases Chinese Han N=196 95/101 37.76 194/2
Symptomatic n=92; primary syphilis n=19, secondary syphilis n=73 92/0
Latent syphilis n=104; early latent n=102, late latent n=2 102/2
Controls Chinese Han N=500 357/143 30.25
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Ministry of Health of the People’s Republic of China (WS 273-
2007). The toluidine red unheated serum test (TRUST) and the T.
pallidum particle agglutination assay test (TPPA) were performed
for all patients. Both TRUST and TPPA were positive for the 196
patients; the TRUST titer ranged from 1:4 to 1:128. Ninety-two
cases had early infectious syphilis (symptomatic syphilis: 19
patients with primary syphilis and 73 with secondary syphilis)
and 104 cases had latent syphilis (102 early latent syphilis (<2
years) and two late latent syphilis (>2 years)). Primary and
secondary syphiliswere diagnosed on the basis of clinical features
and a dark-ﬁeld microscope test from a lesion, also supported by
positive TRUST and TPPA results. Latent syphiliswas diagnosed on
the basis of positive results to the two serological tests in at least
two separate samples of blood, in the absence of clinical signs over
a 3-month period from the last exposure to the infection. Case
patients ranged in age from 19 to 86 years, with a mean age of
37.76 years.
The control sample consisted of 500 randomly selected blood
donors of the same ethnic origin as the patients; both TRUST and
TPPA were negative for all control patients. Their ages ranged from
18 to 56 years, with a mean age of 30.25 years.
All the subjects were negative for HIV (antibody test) and all
patients gave informed consent to participate in the study. The
protocol was approved by the Ethics Committee of the Shandong
Provincial Institute of Dermatovenereology.
DNA extraction and HLA-DRB1* typing
Genomic DNA was extracted from peripheral blood using a
standard phenol–chloroform extraction procedure. DNA samples
were analyzed for quality using a Nanodrop Spectrophotometer
(ND-1000) and electrophoresis assay.
HLA-DRB1 genotyping was done using the HLA-DRB1*SSP
Blood Kit (Protrans Co., Germany). The sequence-speciﬁc primers
for the PCR have been described previously by Olerup and
Zetterquist19 and Bunce et al.20 The PCR reaction was followed
by 36 cycles of denaturation (94 8C, 35 s), annealing (60 8C, 45 s),
and extension (72 8C, 35 s). A ﬁnal extension step (72 8C, 5 min)
terminated the reaction and it was held at 4 8C. The results of
ampliﬁcation were surveyed using an electrophoresis assay.[(Figure_1)TD$FIG]Figure 1. Electrophoresis of PCR products from four samples. From left to right,
electrophoresis gels under UV light: ﬁrst sample: lanes 7, 9, 15, 18, 22, and 23 see a
clear DNA band above the internal contrast lane; second sample: lanes 8, 11, and 23
see a clear DNA band above the internal contrast lane; third sample: lanes 3, 15, 18,
20, 21, and 22 see a clear DNA band above the internal contrast lane; fourth sample:
lanes 9, 11, and 23 see a clear DNA band above the internal contrast lane.Statistical analysis
Allele frequencies were calculated by direct counting. The
signiﬁcance of the difference in allele frequency between the
patients and controls was analyzed using Fisher’s exact probability
test. The nominal p-values were then corrected formultiple testing
(corrected p-value) using the Bonferroni correction, i.e., by
multiplying the nominal p-values by the number of HLA alleles
being tested. A corrected p-value of <0.05 was accepted as
statistically signiﬁcant. The strength of association was estimated
by calculating the odds ratio (OR). Statistical analysis was carried
out using SPSS software (version 11.5; IBM SPSS, Chicago, IL, USA).
Results
Figure 1 shows examples of the electrophoresis of the PCR
products. Table 2 summarizes the frequencies of the HLA-DRB1*
alleles in the syphilis patients and controls, and the results of the
statistical analysis. Of the 13 HLA-DRB1 alleles investigated, two
alleles, HLA-DRB1*14 and HLA-DRB1*16, showed a signiﬁcant
difference in frequency (p < 0.05) between patients and controls.
ForHLA-DRB1*14, the evidence for association remained signiﬁcant
even after correction for multiple testing (corrected p = 0.013),
with a higher frequency in patients than in controls. In contrast, the
frequency of the HLA-DRB1*16 allele was lower in patients than in
controls; however there was no statistical signiﬁcance after
correction.
We further investigated the role of the HLA-DRB1* alleles in the
different clinical subtypes of syphilis, including symptomatic
syphilis (primary syphilis and secondary syphilis) and latent
syphilis; we then compared patients with controls for the two
subtypes separately (shown in Table 3). Results showed that HLA-
DRB1*14 was signiﬁcantly increased in the symptomatic syphilis
patients compared to the normal controls (0.11 vs. 0.04; p < 0.001,
corrected p < 0.05; OR 2.714).
We also compared the allele frequencies between the
symptomatic syphilis and latent syphilis patients (Table 4).
However, no statistically signiﬁcant difference in allele frequency
was observed.
Discussion
ThirteenHLA-DRB1 alleleswere tested in the Chinese population.
The frequency of the HLA-DRB1*14 allele was signiﬁcantly higher in
the syphilis groups ofpatients than in the controls (0.09vs. 0.04).We
found that HLA-DRB1*14 has a close correlation with syphilis (OR
2.182, 95% conﬁdence interval 1.374–3.465). The frequency of the
HLA-DRB1*16 allele was signiﬁcantly lower in the patients than in
the controls (0.01 vs. 0.03), but there was no statistically signiﬁcant
difference after correction (p = 0.046, correctedp = 0.598;OR0.358).
This result may be related to the selection of the sample or the
statistical analysis of the experimental data.
After comparing the HLA-DRB1* alleles across the different
clinical subtypes of syphilis, we also found that HLA-DRB1*14 was
signiﬁcantly increased in those with symptomatic syphilis
(p < 0.001, corrected p < 0.05). However, no signiﬁcant difference
was observed between those with latent syphilis and the control
Table 3
Allele frequency distribution of HLA-DRB1* in symptomatic syphilis patients and latent syphilis patients vs. controls
Allele Controls
(n=500)
Symptomatic syphilis
(n=92)
Latent syphilis
(n=104)
n AF n AF p-Value Corrected p-Value OR n AF p-Value Corrected p-Value OR
DRB1*01 21 0.02 2 0.01 0.532 0.512 4 0.02 1 0.91
DRB1*03 40 0.04 6 0.03 0.633 0.809 8 0.04 0.918 0.96
DRB1*04 94 0.09 21 0.11 0.397 1.242 24 0.12 0.345 1.26
DRB1*07 160 0.16 30 0.16 0.918 1.023 27 0.13 0.273 0.78
DRB1*08 51 0.05 10 0.05 0.85 1.069 7 0.03 0.287 0.65
DRB1*09 139 0.14 21 0.11 0.364 0.798 26 0.13 0.593 0.89
DRB1*10 12 0.01 3 0.02 0.904 1.365
DRB1*11 66 0.07 9 0.05 0.382 0.728 10 0.05 0.333 0.72
DRB1*12 110 0.11 16 0.09 0.352 0.771 26 0.13 0.533 1.16
DRB1*13 61 0.06 6 0.03 0.126 0.519 13 0.06 0.935 1.03
DRB1*14 43 0.04 20 0.11 <0.001 <0.05 2.714 15 0.07 0.074 1.73
DRB1*15 175 0.18 40 0.22 0.17 1.31 44 0.21 0.213 1.27
DRB1*16 28 0.03 4 0.02 0.474 0.68
n, number of individuals; AF, allelic frequency; OR, odds ratio; CI, conﬁdence interval.
p-Values are from the allele-based test; p-values of <0.05 were considered signiﬁcant and further corrected according to the number of comparisons.
Table 2
Allele frequency distribution of HLA-DRB1* in syphilis patients vs. controls
Allele Patients (n=196) Controls (n=500) p-Value Corrected p-Value OR 95% CI
n AF n AF
DRB1*01 6 0.02 21 0.02 0.488 0.725 0.290–1.809
DRB1*03 14 0.04 40 0.04 0.710 0.889 0.478–1.653
DRB1*04 45 0.11 94 0.09 0.244 1.250 0.858–1.821
DRB1*07 57 0.15 160 0.16 0.500 0.893 0.644–1.240
DRB1*08 17 0.04 51 0.05 0.552 0.844 0.481–1.479
DRB1*09 47 0.12 139 0.14 0.346 0.844 0.593–1.202
DRB1*10 3 0.01 12 0.01 0.676 0.635 0.178–2.262
DRB1*11 19 0.05 66 0.07 0.219 0.721 0.427–1.218
DRB1*12 42 0.11 110 0.11 0.878 0.971 0.666–1.415
DRB1*13 19 0.05 61 0.06 0.366 0.784 0.462–1.330
DRB1*14 35 0.09 43 0.04 0.001 0.013 2.182 1.374–3.465
DRB1*15 84 0.21 175 0.18 0.090 1.286 0.961–1.720
DRB1*16 4 0.01 28 0.03 0.046 0.598 0.358 0.125–1.027
n, number of individuals; AF, allelic frequency; OR, odds ratio; CI, conﬁdence interval.
p-Values are from the allele-based test; p-values of<0.05 were considered signiﬁcant and further corrected according to the number of comparisons.
Table 4
Allele frequency distribution of HLA-DRB1* in the symptomatic syphilis patients vs. the latent syphilis patients
Allele Symptomatic syphilis
(n=92)
Latent syphilis
(n=104)
p-Value Corrected p-Value OR
n AF n AF
DRB1*01 2 0.01 4 0.02 0.689 0.560
DRB1*03 6 0.03 8 0.04 0.755 0.843
DRB1*04 21 0.11 24 0.12 0.969 0.988
DRB1*07 30 0.16 27 0.13 0.352 1.306
DRB1*08 10 0.05 7 0.03 0.315 1.650
DRB1*09 21 0.11 26 0.13 0.741 0.902
DRB1*10 3 0.02
DRB1*11 9 0.05 10 0.05 0.969 1.018
DRB1*12 16 0.09 26 0.13 0.224 0.667
DRB1*13 6 0.03 13 0.06 0.169 0.506
DRB1*14 20 0.11 15 0.07 0.205 1.569
DRB1*15 40 0.22 44 0.21 0.888 1.035
DRB1*16 4 0.02
n, the number of individuals; AF, allelic frequency; OR, odds ratio.
p-Values are from allele-based test.
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syphilis (p > 0.05 for both). These results further conﬁrm that the
HLA-DRB1*14 allele has a close relationship with symptomatic
syphilis (OR 2.714). Further studies should be initiated to
investigate whether these observations reﬂect a true association
or are just due to chance.
In conclusion, our study shows that HLA-DRB1*14 plays an
important role in syphilis in the Chinese population. We speculatethat HLA-DRB1*14 may be involved in the cellular immune
response and in susceptibility to syphilis in this population. Our
ﬁndings on the possible association between HLA-DRB1*14 and
syphilis could be explained by co-existing alleles or immune
response genes in linkage disequilibrium altering disease suscep-
tibility. These studies should be subjected to multivariate analysis
and repeated in patients of other ethnic origins from the same and
different regions.
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